Research Article
HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
Table 1
Clinical patients’ characteristics.
| | Variable | All patients | Blasts in PB Mean % (range) | HLA-G+ blasts (mean %) | HLA-G− blasts (mean %) | value |
| | Number of patients (%) | 22 | 65.6 (13.3–96.4) | 15 (68.2) | 7 (31.8) | | | Age at diagnosis (year) | 59 (22–83) | | | | | | Male (%) | 8 (36) | 73.9 (13.3–94.5) | 8 (100) | 0 (0) | 0.022 | | Female (%) | 14 (64) | 60.8 (23.9–96.4) | 7 (50) | 7 (50) | | | AML | 3 | 58.1 (42.2–85.2) | 2 (66.7) | 1 (33.3) | | | AML-M0 | 2 | 35.6 (25.4–45.7) | 1 (50) | 1 (50) | | | AML-M1 | 1 | 68 | / | 1 (100) | | | AML-M2 | 7 | 62.4 (23.9–94.5) | 5 (71.5) | 2 (28.5) | | | AML-M3 | 1 | 94.4 | 1 (100) | / | | | AML-M4 | 6 | 81.5 (40–95.3) | 4 (66.6) | 2 (33.4) | | | AML-M5a | 1 | 96.4 | 1 (100) | / | | | AML-M6 | 1 | 13.3 | 1 (100) | / | |
|
|
Comparison between HLA-G+ and HLA-G− blasts using Fisher’s exact test.
|
